SLG
LH icon

Stanley-Laman Group’s Labcorp LH Stock Holding History

Stanley-Laman Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,077
Closed -$283K – 289
2025
Q2 		$283K Buy
1,077
+167
+18% +$40.7K 0.04% 245
2025
Q1 		$212K Buy
+910
New +$221K 0.03% 269
2018
Q4 		– Sell
-35,415
Closed -$5.28M – 280
2018
Q3 		$5.28M Sell
35,415
-2,506
-7% -$381K 1.3% 18
2018
Q2 		$5.85M Buy
37,921
+983
+3% +$148K 1.31% 13
2018
Q1 		$5.13M Sell
36,938
-1,383
-4% -$203K 1.17% 18
2017
Q4 		$5.25M Buy
38,321
+1,827
+5% +$241K 1.13% 23
2017
Q3 		$4.73M Buy
36,494
+3,310
+10% +$441K 1.26% 22
2017
Q2 		$4.39M Buy
33,184
+1,184
+4% +$145K 1.19% 20
2017
Q1 		$3.94M Buy
+32,000
New +$3.79M 1.07% 27

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Stanley-Laman Group's LH Position: Q3 2025 in Review

Stanley-Laman Group sold out of Labcorp (LH) in Q3 2025, closing a stake of 1,077 shares — an estimated $283K sold.

Stanley-Laman Group first reported a position in LH in Q1 2017 and held it in 9 quarters. The position peaked at $5.85M in Q2 2018. 1,010 funds tracked by Wall St. Rank hold LH as of Q3 2025.

  • Stanley-Laman Group reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
  • Stanley-Laman Group sold 1,077 Labcorp shares in Q3 2025, an estimated $283K.
  • Stanley-Laman Group first reported a position in Labcorp in Q1 2017 and held it in 9 quarters.
  • Stanley-Laman Group's Labcorp position peaked at $5.85M in Q2 2018.
  • 1,010 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on Stanley-Laman Group's 13F filing for Q3 2025, filed 22 Oct 2025.